NDC 42571-259 – Roflumilast
Roflumilast 500 ug/1 · Tablet · Oral
Product NDC42571-259
Product details
- Brand name
- Roflumilast
- Generic name
- Roflumilast
- Labeler
- Micro Labs Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA208180
- Marketed since
- October 19, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phosphodiesterase 4 Inhibitor
Active ingredients
- Roflumilast 500 ug/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 42571-259-05 | 500 TABLET in 1 BOTTLE (42571-259-05) | Oct 19, 2022 |
| 42571-259-17 | 11 BLISTER PACK in 1 CARTON (42571-259-17) / 10 TABLET in 1 BLISTER PACK (42571-259-32) | Oct 19, 2022 |
| 42571-259-30 | 30 TABLET in 1 BOTTLE (42571-259-30) | Oct 19, 2022 |
| 42571-259-90 | 90 TABLET in 1 BOTTLE (42571-259-90) | Oct 19, 2022 |
Other Roflumilast products
- 60687-786 Roflumilast 500 ug/1 · Tablet · American Health Packaging
- 69292-630 Roflumilast 250 ug/1 · Tablet · Amici Pharma Inc.
- 69292-631 Roflumilast 500 ug/1 · Tablet · Amici Pharma Inc.
- 67877-730 Roflumilast 250 ug/1 · Tablet · Ascend Laboratories, LLC
- 67877-480 Roflumilast 500 ug/1 · Tablet · Ascend Laboratories, LLC
- 59651-275 Roflumilast 500 ug/1 · Tablet · Aurobindo Pharma Limited
- 59651-801 Roflumilast 250 ug/1 · Tablet · Aurobindo Pharma Limited
- 73190-086 Roflumilast 250 ug/1 · Tablet · AvKARE
- 73190-087 Roflumilast 500 ug/1 · Tablet · AvKARE
- 72162-2385 Roflumilast 500 ug/1 · Tablet · Bryant Ranch Prepack
- 31722-623 Roflumilast 500 ug/1 · Tablet · Camber Pharmaceuticals, Inc.
- 31722-676 Roflumilast 250 ug/1 · Tablet · Camber Pharmaceuticals, Inc.